◀ Back to HRAS
HRAS — LGALS1
Pathways - manually collected, often from reviews:
-
NCI Pathway Database Regulation of Ras family activation:
HRAS/GTP/Galectin-1 complex (HRAS-LGALS1)
→
Galectin-1 (LGALS1)
(modification, collaborate)
Paz et al., Oncogene 2001*, Rotblat et al., Cancer Res 2004*, Belanis et al., Mol Biol Cell 2008*
Evidence: physical interaction
-
NCI Pathway Database Regulation of Ras family activation:
HRAS/GTP/Galectin-1 complex (HRAS-LGALS1)
→
HRAS/GTP complex (HRAS)
(modification, collaborate)
Paz et al., Oncogene 2001*, Rotblat et al., Cancer Res 2004*, Belanis et al., Mol Biol Cell 2008*
Evidence: physical interaction
-
NCI Pathway Database Regulation of Ras family activation:
Galectin-1 (LGALS1)
→
HRAS/GTP complex (HRAS)
(modification, collaborate)
Paz et al., Oncogene 2001*, Rotblat et al., Cancer Res 2004*, Belanis et al., Mol Biol Cell 2008*
Evidence: physical interaction
Protein-Protein interactions - manually collected from original source literature:
Studies that report less than 10 interactions are marked with *
Text-mined interactions from Literome
Prior et al., J Cell Biol 2003
:
Galectin-1 stabilizes the association of activated
H-ras with these nonraft microdomains, whereas K-ras clustering is supported by farnesylation, but not geranylgeranylation
Rotblat et al., Cancer Res 2004
(MAP Kinase Signaling System) :
Galectin-1 ( L11A ) predicted from a computed galectin-1 farnesyl binding pocket selectively
inhibits Ras-GTP